GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Return 49.13%
This Quarter Return
+19.47%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$171M
AUM Growth
+$27.5M
Cap. Flow
+$16.5M
Cap. Flow %
9.62%
Top 10 Hldgs %
35.68%
Holding
96
New
28
Increased
10
Reduced
10
Closed
34
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ASMB icon
51
Assembly Biosciences
ASMB
$179M
$511K 0.25%
5,417
GBIM
52
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
$178K 0.09%
+23,500
New +$178K
A icon
53
Agilent Technologies
A
$36.4B
0
ABBV icon
54
AbbVie
ABBV
$376B
0
AGIO icon
55
Agios Pharmaceuticals
AGIO
$2.1B
-20,000
Closed -$1.23M
AMRN
56
Amarin Corp
AMRN
$311M
-10,000
Closed -$218K
ARCT icon
57
Arcturus Therapeutics
ARCT
$455M
0
BMY icon
58
Bristol-Myers Squibb
BMY
$95B
0
BRKR icon
59
Bruker
BRKR
$4.52B
-140,000
Closed -$2.59M
CYH icon
60
Community Health Systems
CYH
$398M
-121,000
Closed -$5.48M
ENTA icon
61
Enanta Pharmaceuticals
ENTA
$190M
-35,000
Closed -$1.39M
EW icon
62
Edwards Lifesciences
EW
$47.5B
-150,000
Closed -$2.55M
EXAS icon
63
Exact Sciences
EXAS
$9.73B
-125,000
Closed -$2.42M
EYPT icon
64
EyePoint Pharmaceuticals
EYPT
$819M
-10,000
Closed -$442K
HCA icon
65
HCA Healthcare
HCA
$96.3B
-60,000
Closed -$4.23M
HRTX icon
66
Heron Therapeutics
HRTX
$202M
-70,000
Closed -$583K
IONS icon
67
Ionis Pharmaceuticals
IONS
$9.46B
0
LPCN icon
68
Lipocine
LPCN
$15.7M
-5,398
Closed -$561K
LRMR icon
69
Larimar Therapeutics
LRMR
$331M
-6,250
Closed -$1.47M
MDT icon
70
Medtronic
MDT
$119B
-30,000
Closed -$1.86M
NBIX icon
71
Neurocrine Biosciences
NBIX
$13.9B
-100,000
Closed -$1.57M
VNDA icon
72
Vanda Pharmaceuticals
VNDA
$274M
0
VRTX icon
73
Vertex Pharmaceuticals
VRTX
$102B
-40,000
Closed -$4.49M
CMRX
74
DELISTED
Chimerix, Inc.
CMRX
-80,500
Closed -$2.22M
ALIM
75
DELISTED
Alimera Sciences, Inc.
ALIM
0